LIT Postdoc Retreat 2025
10.02.2025In January 2025 the first LIT Postdoc Retreat took place in Regensburg.
Category: 1
LIT scientists give insights in T cell therapy for clinicians
06.02.2025LIT scientists Dr. Astrid Holzinger, Dr. Markus Barden and Prof. Hinrich Abken give an overview on CARs, TRUCKS and the next generation of T cell therapy in the journal JATROS Hämatologie & Onkologie.
Scientist Roland C. Schelker earns his second doctorate (PhD) with summa cum laude at the LIT
03.02.2025The Leibniz Institute for Immunotherapy (LIT) is pleased to announce the successful completion of Dr. Roland C. Schelker’s second doctoral degree.
Podcast “ImmunVERMITTELT”: Prof. Philipp Beckhove gives insights into tumor immunology
16.01.2025Prof. Philipp Beckhove, Scientific Director of the LIT, was guest in the podcast “ImmunVERMITTELT” by Janssen-Cilag GmbH.
High-profile LIT publication sparks global discussion
10.01.2025Recent work by LIT scientists Prof. Luca Gattinoni and Dr. Jeremy Baldwin published in Cell has generated significant interest both inside and outside the cancer immunology field.
LIT Scientist Caio Silveira talks about “Research in Germany” in new BMBF campaign
15.11.2024Dr. Caio Silveira, postdoctoral scientist in the Research Division ‘Functional Immune Cell Modulation’, participated in a new campaign by the Federal Ministry of Education and Research (BMBF).
Four LIT scientists among Stanford’s top 2% of scientists worldwide
01.10.2024LIT scientists Prof. Hinrich Abken, Prof. Markus Feuerer, Prof. Luca Gattinoni and Prof. Michael Rehli are featured in the prestigious Stanford ranking of the world’s top 2% of scientists.
LIT Retreat 2024
26.09.2024The LIT Retreat took place on September 16 and 17, 2024 at Schloss Hirschberg.
Best Abstract Award for LIT Scientist Gabriele Inchingolo
20.09.2024Gabriele Inchingolo was honored as one of the Best Abstract Awardees at the 3rd Translational Research Conference “IMMUNE & CELLULAR THERAPIES: Focus on Advanced Gene-Engineered Immune Cells” September 13-15, 2024 in Malahide (Dublin), Ireland.
Mitochondria on the move: Leveraging intercellular mitochondria transfer to boost cancer immunotherapies
13.09.2024An international team of researchers, led by Professor Luca Gattinoni at the Leibniz Institute for Immunotherapy (LIT), has developed an innovative mitochondrial transfer platform to supercharge CD8+ T cells, enabling them to overcome exhaustion and more effectively fight tumor cells.
